Ken Griffin's position in Recursion Pharmaceuticals is currently worth $286 Thousand. That's 0.00% of their equity portfolio (3857th largest holding). The first Recursion Pharmaceuticals trade was made in Q4 2021. Since then Ken Griffin bought shares four more times and sold shares on four occasions. The investor's estimated purchase price is $408 Thousand, resulting in a loss of 30%.